Cocrystal Ptb Ratio vs Capex To Revenue Analysis

COCP Stock  USD 1.46  0.05  3.55%   
Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Ptb Ratio and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Ptb Ratio vs Capex To Revenue

Ptb Ratio vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Ptb Ratio account and Capex To Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cocrystal Pharma's Ptb Ratio and Capex To Revenue is -0.07. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Ptb Ratio and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Cocrystal Pharma are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ptb Ratio i.e., Cocrystal Pharma's Ptb Ratio and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.07
Relationship DirectionNegative 
Relationship StrengthInsignificant

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.As of 04/25/2025, Enterprise Value is likely to grow to about 154.1 M, while Selling General Administrative is likely to drop slightly above 4.2 M.
 2022 2023 2024 2025 (projected)
Total Operating Expenses18.1M22.5M17.9M21.5M
Cost Of Revenue241.6K15.2K13.7K13.0K

Cocrystal Pharma fundamental ratios Correlations

0.190.61-0.010.270.16-0.040.98-0.43-0.020.55-0.080.030.77-0.050.590.28-0.430.06-0.51-0.29-0.410.70.42-0.410.37
0.19-0.270.40.60.06-0.390.25-0.14-0.380.12-0.36-0.630.46-0.330.150.930.19-0.23-0.03-0.490.160.310.770.130.84
0.61-0.27-0.23-0.070.40.180.56-0.690.180.670.140.48-0.030.150.7-0.23-0.410.22-0.42-0.08-0.480.56-0.2-0.45-0.23
-0.010.4-0.230.610.08-0.990.19-0.02-0.990.09-0.81-0.660.16-0.990.090.320.11-0.54-0.20.390.480.250.230.410.41
0.270.6-0.070.61-0.16-0.610.38-0.16-0.610.16-0.46-0.870.39-0.60.260.57-0.02-0.49-0.49-0.060.560.380.480.590.76
0.160.060.40.08-0.16-0.050.17-0.71-0.060.38-0.070.28-0.11-0.070.34-0.180.370.150.31-0.17-0.02-0.08-0.3-0.09-0.22
-0.04-0.390.18-0.99-0.61-0.05-0.240.041.0-0.120.820.64-0.191.0-0.13-0.340.00.540.29-0.4-0.41-0.33-0.28-0.35-0.43
0.980.250.560.190.380.17-0.24-0.43-0.230.55-0.24-0.10.79-0.260.60.33-0.42-0.06-0.55-0.19-0.310.740.46-0.320.44
-0.43-0.14-0.69-0.02-0.16-0.710.04-0.430.05-0.650.11-0.120.010.06-0.65-0.060.13-0.130.180.270.1-0.280.050.11-0.09
-0.02-0.380.18-0.99-0.61-0.061.0-0.230.05-0.120.820.63-0.171.0-0.13-0.32-0.010.530.29-0.41-0.42-0.32-0.26-0.36-0.42
0.550.120.670.090.160.38-0.120.55-0.65-0.12-0.190.10.15-0.130.980.12-0.250.24-0.27-0.03-0.220.470.08-0.260.13
-0.08-0.360.14-0.81-0.46-0.070.82-0.240.110.82-0.190.48-0.210.8-0.14-0.330.00.020.13-0.43-0.34-0.22-0.26-0.27-0.39
0.03-0.630.48-0.66-0.870.280.64-0.1-0.120.630.10.48-0.350.620.05-0.58-0.130.570.190.05-0.68-0.08-0.49-0.68-0.75
0.770.46-0.030.160.39-0.11-0.190.790.01-0.170.15-0.21-0.35-0.190.180.54-0.22-0.11-0.3-0.3-0.140.440.7-0.160.66
-0.05-0.330.15-0.99-0.6-0.071.0-0.260.061.0-0.130.80.62-0.19-0.14-0.280.010.560.31-0.42-0.42-0.33-0.23-0.36-0.39
0.590.150.70.090.260.34-0.130.6-0.65-0.130.98-0.140.050.18-0.140.16-0.260.17-0.38-0.06-0.20.540.11-0.210.19
0.280.93-0.230.320.57-0.18-0.340.33-0.06-0.320.12-0.33-0.580.54-0.280.16-0.12-0.21-0.25-0.43-0.020.470.93-0.050.92
-0.430.19-0.410.11-0.020.370.0-0.420.13-0.01-0.250.0-0.13-0.220.01-0.26-0.120.030.78-0.010.56-0.64-0.370.53-0.22
0.06-0.230.22-0.54-0.490.150.54-0.06-0.130.530.240.020.57-0.110.560.17-0.210.030.290.0-0.33-0.22-0.21-0.32-0.32
-0.51-0.03-0.42-0.2-0.490.310.29-0.550.180.29-0.270.130.19-0.30.31-0.38-0.250.780.29-0.020.26-0.78-0.410.18-0.42
-0.29-0.49-0.080.39-0.06-0.17-0.4-0.190.27-0.41-0.03-0.430.05-0.3-0.42-0.06-0.43-0.010.0-0.020.31-0.17-0.40.24-0.35
-0.410.16-0.480.480.56-0.02-0.41-0.310.1-0.42-0.22-0.34-0.68-0.14-0.42-0.2-0.020.56-0.330.260.31-0.49-0.190.980.17
0.70.310.560.250.38-0.08-0.330.74-0.28-0.320.47-0.22-0.080.44-0.330.540.47-0.64-0.22-0.78-0.17-0.490.56-0.460.46
0.420.77-0.20.230.48-0.3-0.280.460.05-0.260.08-0.26-0.490.7-0.230.110.93-0.37-0.21-0.41-0.4-0.190.56-0.220.91
-0.410.13-0.450.410.59-0.09-0.35-0.320.11-0.36-0.26-0.27-0.68-0.16-0.36-0.21-0.050.53-0.320.180.240.98-0.46-0.220.15
0.370.84-0.230.410.76-0.22-0.430.44-0.09-0.420.13-0.39-0.750.66-0.390.190.92-0.22-0.32-0.42-0.350.170.460.910.15
Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets54.2M79.4M40.8M31.3M13.5M12.8M
Total Current Liabilities1.4M1.5M1.2M3.3M2.4M2.7M
Total Stockholder Equity52.5M77.5M39.6M26.4M9.5M9.0M
Net Debt(32.4M)(58.2M)(36.8M)(24.5M)(8.1M)(8.5M)
Retained Earnings(244.9M)(259.1M)(297.9M)(315.9M)(333.4M)(316.7M)
Accounts Payable657K578K614K1.2M1.5M1.0M
Cash33.0M58.7M37.1M26.4M9.9M11.9M
Non Current Assets Total20.2M20.1M662K2.2M1.9M1.8M
Cash And Short Term Investments33.0M58.7M37.1M26.4M9.9M12.0M
Common Stock Shares Outstanding55.2M88.4M8.1M9.7M10.2M13.0M
Liabilities And Stockholders Equity54.2M79.4M40.8M31.3M13.5M12.8M
Other Stockholder Equity297.3M336.5M337.5M342.3M342.9M180.0M
Total Liab1.7M1.8M1.3M4.9M3.9M3.7M
Total Current Assets34.0M59.3M40.2M29.1M11.6M13.5M
Common Stock71K98K8K10K11.5K10.9K
Other Current Liab267K495K122K1.8M585K555.8K
Property Plant And Equipment Net1.1M931K616K2.1M1.8M1.0M
Other Current Assets449K618K2.3M1.8M505K333.8K
Property Plant And Equipment Gross1.1M2.4M2.2M3.9M3.8M4.0M
Net Receivables556K0.0716K890K1.2M607.7K
Short Long Term Debt Total596K534K297K1.9M1.8M1.5M
Non Current Liabilities Total379K298K57K1.6M1.5M1.4M
Short Term Debt434K472K480K240K301K286.0K
Net Tangible Assets6.6M33.4M58.5M39.6M35.6M34.6M
Other Assets544K46K0.01.00.90.86
Property Plant Equipment1.1M1.1M931K616K708.4K640.6K
Net Invested Capital52.5M77.5M39.6M26.4M9.5M9.0M

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.